组织工程与重建外科杂志

组织工程与重建外科杂志 ›› 2024, Vol. 20 ›› Issue (5): 528-.

• • 上一篇    下一篇

射频消融联合泡沫硬化剂治疗儿童KlippelTrenaunay综合征的疗效分析

  

  • 出版日期:2024-10-08 发布日期:2024-11-25

Analysis of the therapeutic effect of radiofrequency ablation combined with foam sclerosant on the treatment of Klippel-Trenaunay syndrome in children

  • Online:2024-10-08 Published:2024-11-25

PDF (PC)

16

摘要：

　目的　探讨射频消融（RFA）联合泡沫硬化剂治疗儿童 Klippel-Trenaunay 综合征（KTS）的安全性及疗效。方法　收集2022年4月至2024年4月收治的30例KTS患儿的临床资料，均采用RFA联合泡沫硬化剂治疗，随访边缘静脉闭合情况和并发症发生情况。结果 30例KTS患儿中28例边缘静脉完全闭合，2例部分闭合，0例仍通畅，完全闭合率93.3%（28/30）；所有患儿均未出现低氧血症、肺动脉高压、神经损伤、皮肤坏死、深静脉血栓及血红蛋白尿等严重并发症。结论 RFA联合泡沫硬化剂治疗儿童KTS具有较高的安全性和有效性。

关键词:

Abstract:

 Objective To explore the safety and efficacy of radiofrequency ablation （RFA） combined with foam
sclerosant in the treatment of Klippel-Trenaunay syndrome （KTS） in children. Methods The clinical data of 30 children
with KTS from April 2022 to April 2024 was collected. All patients were treated with RFA combined with foam sclerosant，
and the marginal vein closure and complications were followed up. Results Among 30 cases of KTS，28 cases of marginal
vein were completely closed，2 cases were partially closed， and 0 case was still unobstructed， with a complete closure rate of
93.3% （28/30）. All patients did not experience severe complications such as hypoxemia， pulmonary arterial hypertension，
nerve damage， skin necrosis， deep vein thrombosis， or hemoglobinuria. Conclusion RFA combined with foam sclerosant is
safe and effective in the treatment of KTS in children.

Key words:

中图分类号: